共催：医学セミナー／第69回免疫学セミナー
ＳＰＥＣＩＡＬ ＳＥＭＩＮＡＲ
◆共催：医学セミナー／第69回免疫学セミナー◆
【演題】TARGETING INNATE IMMUNITY
IN TREATING AUTOIMMUNE AND INFLAMMATORY DISEASES
【Guest Speaker】Dr. Lih Ling-Lin
【所属】Senior Director, Head of Innate Immunity of Inflammation
and Immunology Research Unit in Pfizer
【日時】Thu. October12 15:00-17:00
【場所】Room 411 in Medical Gakugun-to 4A Bldg.
【Abstract】Innate immune system detects danger signals derived from microbial products and
endogenous ligands. These danger signals can initiate and perpetuate inflammation and
autoimmunity via recognition of pattern recognition receptors such as Toll like receptor (TLR).
We aim to develop transformative therapies in treating patients with autoimmune and inflammatory
diseases by targeting danger signal pathways contributing to key disease mechanisms. IRAK4 is an
essential kinase that mediates TLR and IL-1R signaling. We have developed a potent and selective IR
AK4 inhibitor with a potential to become a novel and transformative therapy in treating autoimmune
diseases such as Rheumatoid Arthritis and Lupus.
セミナーは英語で行われます。
This seminar will be held in English.
詳細はこちらをご覧下さい。 seminar69
問合せ先： 医学医療系・免疫学
渋谷 彰 (ashibuya@md.tsukuba.ac.jp)
029-853-3281
たくさんのご来場お待ちしております。